MoneyWorks4Me

Ipca Laboratories reports 6% fall in Q2 consolidated net profit

13 Nov 2023 Evaluate

Ipca Laboratories has reported results for second quarter ended September 30, 2023 (Q2FY24). 

The company has reported 2.11% fall in its net profit at Rs 162.13 crore for the quarter under review as compared to Rs 165.63 crore for the same quarter in the previous year. However, total income of the company increased by 11.02% at Rs 1,698.81 crore for Q2FY24 as compared to Rs 1,530.16 crore for the corresponding quarter previous year.

On consolidated basis, the company has reported 6.39% fall in its net profit at Rs 137.44 crore for Q2FY24 as compared to Rs 146.82 crore for the same quarter in the previous year. However, total income of the company increased by 26.59% at Rs 2,072.51 crore for Q2FY24 as compared to Rs 1,637.18 crore for the corresponding quarter previous year.

Peers
Company Name CMP
Sun Pharma. Inds. 1853.50
Dr. Reddys Labs. 1202.80
Cipla 1397.20
Lupin 2090.00
Zydus Lifesciences 1202.00
View more..